Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Yu-Yan Xiong"'
Autor:
Jun Xu, Yu‐Yan Xiong, Qing Li, Meng‐Jin Hu, Pei‐Sen Huang, Jun‐Yan Xu, Xia‐Qiu Tian, Chen Jin, Jian‐Dong Liu, Li Qian, Yue‐Jin Yang
Publikováno v:
Stem Cells Translational Medicine, Vol 8, Iss 10, Pp 1068-1083 (2019)
Abstract Our previous studies showed that the combination of atorvastatin (ATV) and single injection of ATV‐pretreated mesenchymal stem cells (MSCs) (ATV‐MSCs) at 1 week post‐acute myocardial infarction (AMI) promoted MSC recruitment and surviv
Externí odkaz:
https://doaj.org/article/57d7d78e30a040a482f09c50611cba82
Autor:
Jun Zhang, Hong Wang, Yuan Wu, Yue-Jin Yang, Hai-Yan Qian, Lei Song, Yong-Jian Geng, Run-lin Gao, Xia-Qiu Tian, Ji Huang, Pei-Sen Huang, Jun Xu, Rui Shen, Min-Jie Lu, Shi-Hua Zhao, Wei-Chun Wu, Jie Qian, Jun-Yan Xu, Yu-Yan Xiong
Publikováno v:
Open Heart, Vol 7, Iss 1 (2020)
Objective To test whether intensive atorvastatin (ATV) increases the efficacy of transplantation with autologous bone marrow mononuclear cells (MNCs) in patients suffering from anterior ST-elevated myocardial infarction (STEMI).Methods This clinical
Externí odkaz:
https://doaj.org/article/4b539f3c0cfc4e419d1ce3c82efc31e5
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Type 2 immunity participates in the pathogeneses of helminth infection and allergic diseases. Emerging evidence indicates that the components of type 2 immunity are also involved in maintaining metabolic hemostasis and facilitating the healing proces
Externí odkaz:
https://doaj.org/article/06a6995fa95048c186c48f8f80293831
Autor:
Li-li Zhang, Gui-hao Chen, Rui-jie Tang, Yu-yan Xiong, Qi Pan, Wen-yang Jiang, Zhao-ting Gong, Cheng Chen, Xiao-song Li, Yue-jin Yang
Publikováno v:
Cardiovascular Drugs and Therapy.
Publikováno v:
International Journal of Nanomedicine
Despite several recent advances, current therapy and prevention strategies for myocardial infarction are far from satisfactory, owing to limitations in their applicability and treatment effects. Nanoparticles (NPs) enable the targeted and stable deli
Autor:
Xiao-Tong Lu, Yu Ning, Jing Xu, Rui-Jie Tang, Cun-Rong Huang, Chun-Xiao Wu, Yu-Yan Xiong, Chen Jin, Wen-Yang Jiang, Gui-Hao Chen, Xiangdong Li, Yi Xu, Meng-Jin Hu, Jun Xu, Pei-Sen Huang, Hai-Yan Qian, Yuejin Yang, Jun-Yan Xu, Zhao-Ting Gong
Publikováno v:
Cardiovascular Research. 118:2165-2178
Aims Interleukin (IL)-5 mediates the development of eosinophils (EOS) that are essential for tissue post-injury repair. It remains unknown whether IL-5 plays a role in heart repair after myocardial infarction (MI). This study aims to test whether IL-
Publikováno v:
Stem Cells and Development. 30:561-577
Acute myocardial infarction (AMI) is an event of ischemic myocardial necrosis caused by acute coronary artery occlusion, which ultimately leads to a large loss of cardiomyocytes. The prerequisite of salvaging ischemic myocardium and improving cardiac
Autor:
Joseph A. Hill, Yuejin Yang, Chen Jin, Cong Wei, Chuansheng Xu, Rui-Jie Tang, Guihao Chen, Jun Xu, Li-ping Chang, Xiangdong Li, Yu-Yan Xiong, Qing Li, Yu Ning, Cun-Rong Huang, Thomas G. Gillette, Pei-Sen Huang, Xia-Qiu Tian, Tongyi Huang, Qinfeng Li, Jun-Yan Xu
Publikováno v:
Theranostics
Rationale: The crosstalk between cardiac microvascular endothelial cells (CMECs) and cardiomyocytes (CMs) has emerged as a key component in the development of, and protection against, cardiac diseases. For example, activation of endothelial nitric ox
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine
Cardiac fibrosis, a common pathophysiologic process in most heart diseases, refers to an excess of extracellular matrix (ECM) deposition by cardiac fibroblasts (CFs), which can lead to cardiac dysfunction and heart failure subsequently. Not only CFs
Publikováno v:
Journal of Visualized Experiments.
Revascularization therapies for culprit arteries, regardless of percutaneous coronary intervention and coronary artery bypass grafting, are considered the best strategy for improving the clinical prognosis of patients with acute coronary syndrome (AC